1 – 11 of 11
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Impact of ferric carboxymaltose for iron deficiency at discharge after heart failure hospitalization : a European multinational economic evaluation
(
- Contribution to journal › Article
- 2020
-
Mark
Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial
(
- Contribution to journal › Article
- 2019
-
Mark
Rationale and design of the AFFIRM-AHF trial : a randomised, double-blind, placebo-controlled trial comparing the effect of intravenous ferric carboxymaltose on hospitalisations and mortality in iron-deficient patients admitted for acute heart failure
(
- Contribution to journal › Article
- 2015
-
Mark
The impact of intravenous ferric carboxymaltose on renal function: an analysis of the FAIR-HF study
(
- Contribution to journal › Article
- 2013
-
Mark
The effect of intravenous ferric carboxymaltose on health-related quality of life in patients with chronic heart failure and iron deficiency: a subanalysis of the FAIR-HF study
(
- Contribution to journal › Article
-
Mark
Intravenous ferric carboxymaltose in iron-deficient chronic heart failure patients with and without anaemia: a subanalysis of the FAIR-HF trial
(
- Contribution to journal › Article
- 2011
-
Mark
Effect on Mode of Death of Heart Failure Treatment Started with Bisoprolol Followed by Enalapril, Compared to the Opposite Order: Results of the Randomized CIBIS III Trial
(
- Contribution to journal › Article
- 2009
-
Mark
Rationale and design of Ferinject((R)) Assessment in patients with IRon deficiency and chronic Heart Failure (FAIR-HF) study: a randomized, placebo-controlled study of intravenous iron supplementation in patients with and without anaemia
(
- Contribution to journal › Article
-
Mark
Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency.
(
- Contribution to journal › Article
- 2005
-
Mark
Effect on Survival and Hospitalization of Initiating Treatment for Chronic Heart Failure With Bisoprolol Followed by Enalapril, as Compared With the Opposite Sequence. Results of the Randomized Cardiac Insufficiency Bisoprolol Study (CIBIS) III.
(
- Contribution to journal › Article
- 2004
-
Mark
Comparison of treatment initiation with bisoprolol vs. enalapril in chronic heart failure patients: rationale and design of CIBIS-III.
(
- Contribution to journal › Article